The first clinical trial of medical marijuana for PTSD has concluded. It was performed at the Scottsdale Research Institute by Dr. Sue Sisley.
The FDA-approved study had 76 veterans with PTSD participate, KJZZ 91.5 Radio reports. The veterans used marijuana for three weeks and then had to abstain for two.
The participants had four strains of marijuana available to them. Each strain containing different cannabinoids. The veterans then determined when they needed to medicate and how much they needed to use. There was a cap of 1.8 grams per day.
“Sometimes we saw veterans that had no symptoms on a good day and they wouldn’t use any cannabis,” said Dr. Sisley. “Others would use it only at night to initiate sleep or to suppress nightmares or flashbacks.”
This was a triple-blind, randomized control trial. The participants, independent raters and researchers didn’t know what was being administered to each veteran.
“All of the data from this study, the good and the bad of cannabis, will be published,” noted Sisley. “Everything gets put into the public domain so that everyone gets a chance to scrutinize it.”
Sisley mentioned that there hasn’t been a new treatment for PTSD in over 17 years. Marijuana could become a lifesaver for those living with PTSD.